Can glypican-3 be a disease-specific biomarker?

BACKGROUND: Glypican-3 (GPC3) is a cell surface-bound proteoglycan which has been identified as a potential biomarker candidate in hepatocellular carcinoma, lung carcinoma, severe pneumonia, and acute respiratory distress syndrome (ARDS). The aim of our review is to evaluate whether GPC3 has utility...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Chaolei, Huang, Xiaomin, Ying, Zhaojian, Wu, Dengmin, Yu, Yani, Wang, Xiangdong, Chen, Chengshui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433957/
https://www.ncbi.nlm.nih.gov/pubmed/28510121
http://dx.doi.org/10.1186/s40169-017-0146-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433957/
https://www.ncbi.nlm.nih.gov/pubmed/28510121
http://dx.doi.org/10.1186/s40169-017-0146-5

Ejemplares similares